TZUTC: -0500   
   MSGID: 16.consprcy@1:2320/105 2bf79f7f   
   PID: Synchronet 3.20a-Linux master/acc19483f Apr 26 202 GCC 12.2.0   
   TID: SBBSecho 3.20-Linux master/acc19483f Apr 26 2024 23:04 GCC 12.2.0   
   BBSID: CAPCITY2   
   CHRS: ASCII 1   
   From TLDR 2025-01-22   
      
    DEEPMIND'S HASSABIS SEES AI-DESIGNED DRUG TRIALS THIS YEAR (2 MINUTE READ) [8]   
      
    Isomorphic Labs' Nobel Prize-winning chief executive officer says   
   that the company will hopefully have some AI-designed drugs in   
   clinical trials by the end of the year. It is working on shortening   
   the drug discovery process from a decade or more to just weeks or   
   months. The company, created in 2021 to commercialize Google   
   DeepMind's AlphaFold AI for drug discovery, announced strategic   
   research collaboration agreements with Eli Lilly & Co. and Novartis AG   
   last year. AlphaFold can model a range of molecular structures and   
   predict how they interact with each other.    
      
   [8] https://www.yahoo.com/news/deepmind-hassabis-sees-ai-designed-152419324.htm   
   l?utm_source=tldrnewsletter   
      
    --  https://tldr.tech   
      
   $$   
   --- SBBSecho 3.20-Linux   
    * Origin: capitolcityonline.net * Telnet/SSH:2022/HTTP (1:2320/105)   
   SEEN-BY: 105/81 106/201 128/187 129/305 153/7715 154/110 218/700 226/30   
   SEEN-BY: 227/114 229/110 111 114 206 300 307 317 400 426 428 470 664   
   SEEN-BY: 229/700 705 266/512 291/111 320/219 322/757 342/200 396/45   
   SEEN-BY: 460/58 712/848 902/26 2320/0 105 3634/12 5075/35   
   PATH: 2320/105 229/426